31 results on '"Soejima, Yoshifumi"'
Search Results
2. Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer
3. A case of Serratia granuloma in the soft tissue around the left kidney: a role of PTHrP in the formation of Serratia granuloma
4. Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
5. A phase I trial of carboplatin and etoposide for elderly (≥75 year-old) patients with small-cell lung cancer
6. Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
7. Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia
8. Phase I Study of Irinotecan and Gemcitabine in Previously Untreated Patients with Advanced Non-small Cell Lung Cancer
9. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy
10. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy
11. The Japanese Society of Internal Medicine
12. A Clinical Study on Serum Pepsinogen in 81 Patients Undergoing Gastric Examination
13. Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)
14. Updated overall survival (OS) results of randomized phase III trial of erlotinib (E) versus (v) docetaxel (D) as second- or third-line therapy in patients with advanced non-small cell lung cancer (NSCLC): Docetaxel and Erlotinib Lung Cancer Trial (DELTA).
15. Randomized phase III trial of erlotinib (E) versus docetaxel (D) as second- or third-line therapy in patients with advanced non-small cell lung cancer (NSCLC) who have wild-type or mutant epidermal growth factor receptor (EGFR): Docetaxel and Erlotinib Lung Cancer Trial (DELTA).
16. A Clinical Study of 34 Malignant Pleural Mesothelioma Patients Treated with Pemetrexed from Nagasaki Thoracic Oncology Group
17. A Case of Mycobacterium intracellulare Pulmonary Infection with Vertebral Osteomyelitis
18. Leukocytoclastic Vasculitis after Pneumococcal pneumonia in an Elderly Adult
19. Case Report of Disseminated Nocardiosis Complicated in an Elderly Person with Pneumoconiosis
20. Hepatic Artery Pseudoaneurysms in a Patient Treated for Miliary Tuberculosis.
21. A Randomized Prospective Study of Imipenem-Cilastatin With or Without Amikacin as an Empirical Antibiotic Treatment for Febrile Neutropenic Patients
22. Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay
23. A new MTT assay for examining the cytotoxicity of activated macrophages towards the non-adherent P388 leukaemia cell line
24. Prognostic Factors in Small Cell Lung Cancer: Multivariate Analysis in the National Cancer Center Hospital (Japan).
25. A case of pseudolymphoma of the lung and submandibular gland.
26. [Clinical characteristics of pneumonia in the oldest old patients].
27. [A case of multiple nodular pulmonary amyloidosis complicated with primary Sjogren syndrome].
28. [Case report of disseminated nocardiosis complicated in an elderly person with pneumoconiosis].
29. [A case of pulmonary Mycobacterium gordonae infection with pleural effusion].
30. [Efficacy of docetaxel (TXT) combined with cisplatin (CDDP) in non-small cell lung cancer].
31. [A case of pulmonary involvement of malignant lymphoma with diffuse ground-glass opacity in chest CT].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.